期刊文献+

高浓度枸橼酸钠抗凝在维持性血液透析中的安全性探讨 被引量:8

Security of high concentration sodium citrate anticoagulation in maintenance hemodialysis
在线阅读 下载PDF
导出
摘要 目的观察局部运用高浓度枸橼酸钠抗凝在维持性血液透析治疗中的疗效及安全性。方法有出血倾向患者组以30%枸橼酸钠体外抗凝透析,常规治疗组以低分子肝素抗凝透析作为对照,记录透析前、后实验室检查指标,计算尿素清除指数值,并观察透析器及管路凝血情况。结果枸橼酸钠抗凝组透析前、后Na^+变化存在统计学差异,两组透析前、后Ca^2+、pH、HCO3^-变化也存在差异,两组活化部分凝血活酶时间变化及尿素清除指数值无统计学差异。枸橼酸钠抗凝组未出现低钙、高钠及严重碱血症,且透析器、管路未发生I级以上凝血。结论局部高浓度枸橼酸钠运用于维持性血液透析是安全有效的抗凝方法。 Objective To observe the efficacy and safety of the local use of high concentrations sodium citrate anticoagulation in the maintenance hemodialysis. Methods The group of patients with bleeding tendency were given 30% sodium citrate for extracorporeal anticoagulation in dialysis, and conventional treatment group as a control given low molecular weight heparin for dialysis anticoagulation. Before and after dialysis laboratory parameters were recorded, Kt/V values were calculated, and coagulation conditions of dialyzers and lines were observed. Results There was significant difference in Na^+ changes before and after dialysis in sodium citrate anticoagulation group. There was also significant difference in changes of Ca^2+ , pH, HCO3^- before and after dialysis in two groups. But changes of activated partial thromboplastin time and Kt/V values in two groups showed no significant difference. The symptoms of low calcium, high sodium and severe base acidosis were not observed in sodium citrate anticoagulation group,and coagulation above I level in dialyzers and lines did not occur. Conclusions The local use of high concentration sodium citrate might be a safe and effective anticoagulation method in maintenance hemodialysis.
出处 《临床肾脏病杂志》 2011年第3期114-116,共3页 Journal Of Clinical Nephrology
关键词 肾透析 肝素 血液凝固 出血 Renal Dialysis Heparin Blood Coagulation Hemorrhage
  • 相关文献

参考文献6

二级参考文献40

  • 1傅晓,刘慎微,刘晓城.局部枸橼酸抗凝在不同血液净化方式中的应用[J].国外医学(泌尿系统分册),2005,25(1):139-143. 被引量:8
  • 2王维平,张玉强,叶朝阳,张斌,梅长林.高浓度枸橼酸钠抗凝在高危出血倾向患者常规血液透析中的应用[J].实用心脑肺血管病杂志,2005,13(6):331-334. 被引量:11
  • 3Dean JA. Lange's handbook of chemistry, ed 15th. McGraw-Hill, 1999, Tab8,13.
  • 4Fukuda T, Nakashima Y, Harada M, et al. Effect of whole blood clotting time in rats with ionized hypocaleemia induced by rapid intravenous citrate infusion, J-Toxicol-Sci, 2006, 31 (3): 229 - 234.
  • 5James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography, J-Cardiothorac-Vasc-Anesth, 2004, 18 (5) : 581 - 586.
  • 6Joannidis M. Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care, 2007,11 (4) :218.
  • 7Bunker JP, Bendixen HH, Murphy AJ. Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med, 1962,266: 372 - 377.
  • 8Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and response to i. V. Calcium administration during allogeneie peripheral blood progenitor cell donation. Transfusion, 2002,42 (7) : 935 - 946.
  • 9Bolan CD, Greet SE, Cecco SA, et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion, 2001,41 (9) : 1165 - 1171.
  • 10Bauer E, Derfler K, Joukhadar C, et al. Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis, 2005,46 (5) :903 - 907.

共引文献63

同被引文献46

引证文献8

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部